Enrollment rate refers to the speed at which participants are recruited and included in a clinical trial. It is typically measured as the number of subjects enrolled per unit of time, such as per month or per site per month.
This metric is crucial for assessing the progress and efficiency of a clinical study’s recruitment efforts. A high enrollment rate can indicate successful recruitment strategies and potentially lead to faster study completion, while a low rate may signal challenges in participant acquisition or study design.
Enrollment rate is a critical factor in determining the timeline and success of clinical trials. It directly impacts study duration, budget management, and the ability to meet regulatory deadlines, which are essential for bringing new treatments to market efficiently.
A robust enrollment rate can enhance the statistical power of a study by ensuring an adequate sample size within the planned timeframe. Furthermore, it can influence investor confidence and stakeholder perceptions, potentially affecting future funding and support for clinical research initiatives.
We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…
The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…
The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…
Copyright @ 2025 Axcellant